Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential
暂无分享,去创建一个
P. Negulescu | A. Harootunian | Jesús E González | Michael P Maher | K. McCormack | Jesús E. González | Chien-Jung Huang | M. Maher | C. Quan | C. D. Raj | R. Numann | Chien-Jung Huang | Ken McCormack | Paul A Negulescu | Jesus E. Gonzalez | Alec Harootunian | Catherine Quan | Christopher D Raj | Randal Numann
[1] Wei Zheng,et al. High throughput assay technologies for ion channel drug discovery. , 2004, Assay and drug development technologies.
[2] Masaki Tanaka,et al. Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain , 2004, Pain.
[3] H. White. Comparative Anticonvulsant and Mechanistic Profile of the Established and Newer Antiepileptic Drugs , 1999, Epilepsia.
[4] R Y Tsien,et al. Voltage sensing by fluorescence resonance energy transfer in single cells. , 1995, Biophysical journal.
[5] R Y Tsien,et al. Improved indicators of cell membrane potential that use fluorescence resonance energy transfer. , 1997, Chemistry & biology.
[6] Xi Chen,et al. THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL , 2005, Drug Metabolism and Disposition.
[7] B. Cooper,et al. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. , 1993, The Journal of pharmacology and experimental therapeutics.
[8] M. Maizels,et al. Antidepressants and antiepileptic drugs for chronic non-cancer pain. , 2005, American family physician.
[9] K. Bielefeldt,et al. Amitriptyline Inhibits Voltage-Sensitive Sodium Currents in Rat Gastric Sensory Neurons , 2002, Digestive Diseases and Sciences.
[10] R J Dunn,et al. Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. , 1994, Molecular pharmacology.
[11] P. Negulescu,et al. Cell-based assays and instrumentation for screening ion-channel targets. , 1999, Drug discovery today.
[12] C. Kuo,et al. Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones , 1997, British journal of pharmacology.
[13] B. Roth. Mechanisms for electrical stimulation of excitable tissue. , 1994, Critical reviews in biomedical engineering.
[14] Paul B Bennett,et al. Trends in ion channel drug discovery: advances in screening technologies. , 2003, Trends in biotechnology.
[15] Stable expression and characterization of human PN1 and PN3 sodium channels. , 2003, Receptors & channels.
[16] M. Pera,et al. The Ambiguous Frog: The Galvani-Volta Controversy on Animal Electricity , 1991 .
[17] Chantal Couture,et al. Mechanisms of action , 1994, Schizophrenia Research.
[18] G. Wang,et al. State-dependent block of voltage-gated Na+ channels by amitriptyline via the local anesthetic receptor and its implication for neuropathic pain , 2004, Pain.
[19] Paul Krack,et al. Therapeutic electrical stimulation of the central nervous system. , 2005, Comptes rendus biologies.
[20] Christine Williams,et al. Patch clamping by numbers. , 2004, Drug discovery today.
[21] Andrew E. Dinn,et al. Lidocaine block of neonatal Nav1.3 is differentially modulated by co-expression of β1 and β3 subunits , 2003 .
[22] Derek J Trezise,et al. IonWorks™ HT: A New High-Throughput Electrophysiology Measurement Platform , 2003, Journal of biomolecular screening.
[23] J. Chung,et al. The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation. , 2001, Brain research. Molecular brain research.
[24] A. Scholz,et al. Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. , 2002, British journal of anaesthesia.
[25] Rory Curtis,et al. A Novel Membrane Potential-Sensitive Fluorescent Dye Improves Cell-Based Assays for Ion Channels , 2002, Journal of biomolecular screening.
[26] G. Carter,et al. Antidepressants in pain management. , 2002, Current opinion in investigational drugs.
[27] J. Mao,et al. Systemic lidocaine for neuropathic pain relief , 2000, Pain.
[28] M. Main,et al. An industrial perspective on utilizing functional ion channel assays for high throughput screening. , 2002, Receptors & channels.
[29] T Narahashi,et al. Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels. , 1997, The Journal of pharmacology and experimental therapeutics.
[30] E. Carmeliet,et al. Antiarrhythmic drugs and cardiac ion channels: mechanisms of action. , 1998, Progress in biophysics and molecular biology.
[31] John Garthwaite,et al. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones , 1995, Pflügers Archiv.
[32] S. Dib-Hajj,et al. Pharmacological properties of neuronal TTX-resistant sodium channels and the role of a critical serine pore residue , 2005, Pflügers Archiv.
[33] P. Basser,et al. New currents in electrical stimulation of excitable tissues. , 2000, Annual review of biomedical engineering.
[34] Ya-Chin Yang,et al. Inhibition of Na(+) current by imipramine and related compounds: different binding kinetics as an inactivation stabilizer and as an open channel blocker. , 2002, Molecular pharmacology.
[35] D. Hornung,et al. Use dependence of sodium current inhibition by tetrodotoxin in rat cardiac muscle: influence of channel state , 1990, Pflügers Archiv.
[36] Thomas D. Y. Chung,et al. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.
[37] F. Conti,et al. Use dependence of tetrodotoxin block of sodium channels: a revival of the trapped-ion mechanism. , 1996, Biophysical journal.
[38] W. Catterall,et al. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. , 1994, Science.
[39] S. Y. Wang,et al. Block of human heart hH1 sodium channels by amitriptyline. , 2000, The Journal of pharmacology and experimental therapeutics.
[40] S. Tate,et al. Heterologous expression and functional analysis of rat NaV1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7–23 , 2004, Neuropharmacology.
[41] Salahadin Abdi,et al. The Anti-Allodynic Effects of Amitriptyline, Gabapentin, and Lidocaine in a Rat Model of Neuropathic Pain , 1998, Anesthesia and analgesia.
[42] W. Catterall,et al. Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by local anesthetics. , 1984, Molecular pharmacology.
[43] Clare,et al. Voltage-gated sodium channels as therapeutic targets. , 2000, Drug discovery today.
[44] M. Schulz,et al. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. , 2003, Die Pharmazie.
[45] V. Warren,et al. Functional assay of voltage-gated sodium channels using membrane potential-sensitive dyes. , 2004, Assay and drug development technologies.
[46] R. Vickery,et al. Comparison of the pharmacological properties of rat Na(V)1.8 with rat Na(V)1.2a and human Na(V)1.5 voltage-gated sodium channel subtypes using a membrane potential sensitive dye and FLIPR. , 2004, Receptors & channels.
[47] A. Dubin,et al. Fluorescence Imaging of Electrically Stimulated Cells , 2003, Journal of biomolecular screening.
[48] J J Clare,et al. Cloning, distribution and functional analysis of the type III sodium channel from human brain , 2000, The European journal of neuroscience.
[49] M. Dreimann,et al. Effect of Drugs Used for Neuropathic Pain Management on Tetrodotoxin-resistant Na+ Currents in Rat Sensory Neurons , 2001, Anesthesiology.
[50] K. Courtney. Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. , 1975, The Journal of pharmacology and experimental therapeutics.
[51] W. Agnew,et al. Fluorescence assay for neurotoxin-modulated ion transport by the reconstituted voltage-activated sodium channel isolated from eel electric organ. , 1986, Biochemistry.